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Early Focal Expression of the Chemokine Ccl2 by
Müller Cells during Exposure to Damage-Inducing
Bright Continuous Light
Matt Rutar,1,2 Riccardo Natoli,1,3 Krisztina Valter,1,2 and Jan M. Provis1,2,3
PURPOSE. To investigate the time course and localization of Ccl2
expression and recruitment of inflammatory cells associated
with light-induced photoreceptor degeneration.
METHODS. Sprague-Dawley (SD) rats were exposed to 1000 lux
light for up to 24 hours, after which some animals were
allowed to recover in dim light (5 lux) for 3 or 7 days. During
and after exposure to light, the animals were euthanatized and
the retinas processed. Ccl2 expression was assessed by qPCR,
immunohistochemistry, and in situ hybridization at each time
point. Counts were made of perivascular monocytes/microglia
immunolabeled with ED1, and photoreceptor apoptosis was
assessed with TUNEL.
RESULTS. Upregulation of Ccl2 expression was evident in the
retina by 12 hours of exposure and correlated with increased
photoreceptor death. Ccl2 expression reached its maximum at
24 hours, coinciding with peak cell death. Immunohistochem-
istry and in situ hybridization showed that Ccl2 is expressed by
Müller cells from 12 hours of exposure, most intensely in the
superior retina, in the region of the incipient light-induced
lesion. After the Müller cell-driven expression of Ccl2, there
was a substantial recruitment of monocytes to the local retina
and choroidal vasculature. This coincided spatially with the
expression of Ccl2 in the superior retina. Peak monocyte
infiltration followed maximum Ccl2 expression by up to 3
days. Furthermore, Ccl2 immunoreactivity was observed in
many infiltrating monocytes after a 24-hour exposure.
CONCLUSIONS. The data indicate that photoreceptor death pro-
motes region-specific expression of Ccl2 by Müller cells, which
facilitates targeting of monocytes to sites of injury. The data
suggest that recruitment of monocytes to developing lesions is
secondary to signaling events in the retina. (Invest Ophthalmol
Vis Sci. 2011;52:2379–2388) DOI:10.1167/iovs.10-6010
Microglia are the principal immune cells of the centralnervous system (CNS).1 Through persistent surveillance
of their microenvironment,2 the microglia act after neuronal
stress and injury, maintaining homeostasis in the CNS paren-
chyma, including the retina; facilitating the phagocytosis of
debris and apoptotic cells,3–5 enabling antigen presentation,6,7
and promoting secretion of neuroprotective factors.8 How-
ever, activated microglia may also promote the secretion of the
proinflammatory mediators tumor necrosis factor (TNF)-! and
interleukin (IL)-1",9–11 in addition to cytotoxic factors such as
nitric oxide,12–14 shown to harm neuronal cells.12,15–18 In the
retina, activated microglia respond to degeneration elicited
from a range of human retinal disease, including age-related
macular degeneration (AMD) (Wong JG, et al. IOVS 2001;42:
ARVO Abstract 1222),4,19–21 retinitis pigmentosa,4 and late-
onset retinal degeneration,4 as well as in many experimental
models of retinal degeneration.8 In the light-induced model of
photoreceptor degeneration, recruitment and activation of mi-
croglia in the retina have been particularly well character-
ized22–27 and involve the infiltration of both parenchymal mi-
croglia and perivascular monocytes/microglia to the outer
nuclear layer (ONL) and subretinal space after a damaging
stimulus. Moreover, it has been demonstrated that attenuating
the microglial response results in reduced photoreceptor death
and IL1" production after light-induced damage,26 indicating
that the extensive aggregation and overactivation of microglia
play a role in propagating the neurodegenerative process.
We have shown that light-induced microgliosis of perivas-
cular monocytes is site-specific to the region of peak photore-
ceptor death, at the area centralis of the rat retina.23 However,
the process by which microglia are recruited into the retina
after light-induced damage remains to be clarified. Chemokines
have been shown to have potent chemoattractant properties in
the trafficking of leukocytes in immune surveillance and in-
flammation in the CNS.28–31 Chemokine expression results in
the establishment of chemical ligand gradients that serve as
directional cues for the guidance of certain leukocytes to sites
of injury and are also thought to aid in their extravasation into
tissues.28 Studies have shown that several chemokines are
expressed at high levels after light-induced damage25,32; the
most well-characterized of these being chemokine (C-C motif)
ligand 2 (Ccl2).33 Ccl2 (also known as monocyte chemoattrac-
tant protein 1 [MCP-1]) is a strong chemoattractant for mono-
cytes,34,35 whose upregulation is implicated in several CNS
diseases30,31 including Alzheimer’s disease,36,37 multiple scle-
rosis,38,39 and brain trauma.40,41
We sought to investigate the site and cellular localization of
Ccl2 expression in the retina after photoreceptor death in-
duced by exposure to bright, continuous light (BCL) and to
relate this expression pattern to infiltration of perivascular
monocytes/microglia (hereinafter referred to as monocytes).
Our findings show that in this model, Müller cells located in the
region of the incipient lesion are the early source of Ccl2,
which is upregulated in concert with the onset of photorecep-
tor degeneration. These findings demonstrate the role of the
neural retina in the active initiation of an inflammatory re-
sponse, as a result of light-induced injury. This Müller cell–
driven expression correlates closely with the spatial and tem-
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poral infiltration of monocytes from both the retinal and
choroidal vascular supplies, which in turn were found to ex-
press Ccl2.
METHODS
Animals and Exposure to Light
All experiments conducted were in accordance with the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision Research.
Sprague-Dawley (SD) rats were born and reared in dim cyclic light
conditions with an ambient level of approximately 5 lux. The animals
were exposed to BCL between postnatal day (P)130 and P160. Before
BCL exposure, the animals were dark adapted for a minimum of 15
hours, then transferred to individual cages designed to allow light to
enter unimpeded. BCL exposure, which was achieved with a fluores-
cent light source (18W, Cool White; TFC, Taipei, Taiwan) positioned
above the cages, commenced daily at 9 AM and was maintained at an
intensity of approximately 1000 lux at the cage floor. The animals were
exposed to BCL for a period of 1, 3, 6, 12, 17, or 24 hours, after which
retinal tissue was obtained for analysis. Some animals were returned to
dim-light conditions immediately after 24 hours’ BCL, for a period of 3
or 7 days, while postexposure effects were studied. Age-matched,
dim-light–reared animals served as the controls.
Tissue Collection and Processing
Animals were euthanatized by overdose of a barbiturate administered
by intraperitoneal injection (60 mg/kg bodyweight; Valabarb; Virbac,
Milperra, NSW, Australia). The left eye of each animal was marked at
the superior surface for orientation, enucleated, and processed for
cryosectioning, and the retina of the right eye was excised through a
corneal incision and prepared for RNA extraction.
Eyes for cryosectioning were immediately immersion fixed in 4%
paraformaldehyde in 0.1 M PBS (pH 7.3) for 3 hours at room temper-
ature, then washed in 0.1 M PBS before being left in a 15% sucrose
solution overnight for cryoprotection. Eyes were oriented and embed-
ded in OCT compound (Tissue-Tek; Sakura Fintek, Tokyo, Japan), snap
frozen in liquid nitrogen, and cryosectioned at 16 #m. The sections
were mounted on gelatin/poly-L-lysine–coated glass slides, dried over-
night at 37°C, and stored at !20°C until use.
Retinas for RNA extraction were immediately deposited in RNA
stabilizer (RNAlater solution, cat. no. 7024; Ambion, Austin, TX)
prechilled on ice. The samples were incubated at 4°C overnight to
allow adequate penetration of the preservative, and then stored at
!80°C until required. The samples were processed in batches encom-
passing the entire time course, to ensure comparability. On extraction,
the retinal samples were thawed on ice, and the RNA stabilizer was
removed. RNA extraction was performed with a combination of ex-
traction reagent (TRIzol; cat. no. 15596-026; Invitrogen, Carlsbad, CA)
and a purification kit (RNAqueous-Small Scale, cat. no. 1912; Ambion)
used in tandem to extract and purify the RNA respectively, as de-
scribed in another publication.42 Isolated total RNA was analyzed for
quantity and purity with a spectrophotometer (ND-1000; Nanodrop
Technologies, Wilmington, DE); samples with a 260/280 ratio greater
than 1.90 were considered sufficient. The RNA quality in each sample
was assessed with an RNA analyzer (model 2100 Bioanalyzer; Agilent
Technologies, Santa Clara, CA); only samples with an integrity number
(RIN) of $8 were used.
Quantitative Real-Time Polymerase
Chain Reaction
First-strand cDNA synthesis was performed (SuperScript III Reverse
Transcriptase kit, cat. no. 18080–044; Invitrogen) according to the
manufacturer’s instructions. A 20-#L reaction mixture was used in
conjunction with 1 #g RNA, 500 ng oligo (dT)18 primer, and 200 U
reverse transcriptase. Gene amplification was measured with commer-
cially available hydrolysis probes (TaqMan; Applied Biosystems, Inc.
[ABI], Foster City, CA), the details of which are provided in Table 1.
The hydrolysis probes were applied according to the manufacturer’s
instructions in conjunction with a master mix (Gene Expression Mas-
ter-Mix, cat. no. 4369514; ABI), with the fluorescence measured on a
FAM 510-nm detection channel by a qPCR system (StepOnePlus; ABI).
The samples in each well were normalized by using a passive reference
dye (ROX; ABI), included in the master mix, to account for well-to-well
discrepancies. The amplification of each biological sample was per-
formed in experimental duplicate, with the mean Cq (quantitation
cycle) value used to determine the ratio of change in expression. The
change ratio was determined by using the ""Cq method, where the
expression of the target gene was normalized relative to the expression
of two reference genes, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and actin-" (Actb). Amplification specificity was assessed
with gel electrophoresis.
In Situ Hybridization
To investigate the localization of Ccl2 mRNA transcripts in the retina
after BCL, a riboprobe to Ccl2 was generated for in situ hybridization
on retinal cryosections. Ccl2 was cloned from a PCR product (550-bp
amplicon), with cDNA prepared from rat retinas (as just described), a
DNA vector system (pGEM-T, cat. no. A3600; Promega, Madison, WI),
and TOP10-competent cells (One Shot, cat. no. C4040-10; Invitrogen).
A DIG RNA labeling kit (SP6/T7, cat. no. 1175025; Roche, Basel,
Switzerland) was used to transcribe linearized plasmid and generate
DIG-labeled antisense and sense riboprobes. The in situ hybridization
was performed according to a protocol described elsewhere.43 The
Ccl2 riboprobe was hybridized overnight at 55°C and then washed in
saline sodium citrate (pH 7.4) at 60°C.
Analysis of Cell Death
TUNEL labeling was used to quantify photoreceptor apoptosis during
and after BCL, in cryosections using a protocol published previously.44
Counts of TUNEL# cells in the ONL were performed along the full
length of retinal sections cut in the parasagittal plane (superoinferior),
including the optic disc, in adjacent fields measuring 1000 #m2. The
final count from each animal is the average at comparable locations in
two nonsequential sections.
Immunohistochemistry
Cryosections adjacent to those used in the TUNEL analysis were
used for immunohistochemistry. Details for the primary antibodies
TABLE 1. Hydrolysis Probes Used
Gene Symbol Gene Name Catalog No. Entrez Gene ID
Ccl2 Chemokine (C-C motif) ligand 2 Rn01456716_g1 NM_031530.1
Gfap Glial fibrillary acidic protein Rn00566603_m1 NM_017009.2
GAPDH Glyceraldehyde-3-phosphate dehydrogenase Rn99999916_s1 NM_017008.3
Actb Actin Beta Rn00667869_m1 NM_031144.2
The Entrez database is provided in the public domain by the National Center for Biotechnology
Information, Bethesda, MD.
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used are shown in Table 2. After antigen retrieval (RevealIt Ag;
ImmunoSolution, QLD, Australia), the sections were incubated in
10% normal goat serum (Sigma-Aldrich) for 1 hour at room temper-
ature (RT) and incubated in the primary antibody overnight at 4°C.
The sections were washed in 0.1 M PBS and incubated in the
appropriate biotinylated secondary antibody for 2 hours at RT
(1:200 anti-hamster IgG-biotin; Biolegend, San Diego, CA/ 1:200
biotinylated anti-mouse IgG#A#M; Invitrogen-Molecular Probes,
Eugene, OR). After an additional wash in 0.1 M PBS, the sections
were incubated with a streptavidin – AlexaFluor 594 conjugate
(1:1000; Invitrogen-Molecular Probes) for 1.5 hours at RT. To block
autofluorescence, we performed an incubation using 0.05% Sudan
Black B, as described elsewhere.45 Sections were then stained
(either 1:1000 bis benzamide; Calbiochem, La Jolla, CA, or 1:1000
Syto12; Invitrogen-Molecular Probes), to visualize the cellular lay-
ers, and coverslipped with aqueous mounting medium (Aquamount,
cat. no. 18606; Polysciences, Warrington, PA). Primary antibodies
were omitted to control for nonspecific binding of the secondary
antibody. Immunofluorescence was viewed with a laser scanning
microscope (Carl Zeiss Meditec, Dublin CA) and acquired with
Pascal software (ver. 4.0, Carl Zeiss Meditec). Images were en-
hanced for publication with image-management software (Photo-
shop; Adobe systems, Mountain View, CA), which was standardized
between images.
FIGURE 1. Expression of Ccl2 in the
neural retina by qPCR in relation to
(A) photoreceptor cell death and
(B) GFAP expression, after exposure
to BCL. (A, B) At 12 hours, exposure to
BCL induced a significant increase in
the expression of Ccl2 relative to dim-
light–reared animals (P $ 0.0001,
one-way ANOVA). Ccl2 expression
continued to rise significantly, reach-
ing a peak differential expression of
196,479% by 24 hours. Seven days af-
ter exposure, relative expression had
fallen sharply to 2092%. Large in-
creases in TUNEL# nuclei in the ONL
(A) and GFAP expression (B) were also
observed after 12 hours of exposure
(P $ 0.0001, one-way ANOVA), corre-
lating with the rapid upregulation of
Ccl2 expression over the same period
(interaction 43.60% and 42.82% of to-
tal variance, respectively, P $ 0.0001;
two-way ANOVA). (Ccl2 qPCR, n % 4;
GFAP qPCR, n % 4; TUNEL, n % 5 per
time point; error bars, SEM).
TABLE 2. Antibodies
Antibody Dilution Source
Hamster !-Ccl2 1:100 Cat# 505902; Biolegend, San
Diego, CA
Mouse !-ED1 1:200 Cat# MAB1435; Chemicon,
Temecula, CA
Mouse !-S100" 1:200 Cat# 2532; Sigma-Aldrich, St.
Louis, MO
Mouse !-vimentin 1:200 Cat# MAB302; Chemicon
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Monocyte Quantification
Monocyte counts were performed on sections immunolabeled with
ED-1, a marker for perivascular monocytes/microglia,46 and bis benz-
amide (as per the methodology described earlier). Counts of ED1-
positive nuclei performed along the full length of retinal sections cut in
the parasagittal plane (superoinferior), including the optic disc, in
adjacent fields measuring 1000 #m2. The number of monocytes in the
superficial vasculature, deep vasculature, ONL, and choroidal vascula-
ture were assessed, where the graphs showing the number of ED-1-
positive cells include the total number in each field of view.
Statistical Analysis
Statistical analysis was performed with the one-way ANOVA, two-way
ANOVA, or the unpaired Student’s t-test. For each analysis, differences
with a P $ 0.05 were considered statistically significant. The one-way
ANOVA, and unpaired Student’s t-test were used for the quantification
of TUNEL and monocytes, whereas qPCR results were analyzed by
both the one- and the two-way ANOVA.
RESULTS
Time Course of TUNEL Labeling and GFAP and
Ccl2 Expression
During the first 12 hours of exposure to BCL the average
number of TUNEL# photoreceptors increased from near 0 to
10 (P $ 0.05, Student’s t-test) and reached a peak of 470 by 24
hours of exposure (P $ 0.0001, Student’s t-test). During the
postexposure period, the number of TUNEL# nuclei decreased
to 213 by 3 days and then to 33 after 7 days (P $ 0.01,
Student’s t-test). Using qPCR, we also detected modulation of
GFAP expression over the experimental period (P $ 0.0001,
one-way ANOVA). GFAP expression reached peak levels at 24
hours (2446% relative to control levels) and was somewhat
reduced by 7 days after exposure. These data are shown in
Figure 1, where the expression levels of Ccl2 are plotted
alongside both the time course of photoreceptor death
(TUNEL; Fig. 1A) and expression levels of GFAP (Fig. 1B).
Exposure to BCL induced a significant differential expres-
sion of retinal Ccl2 mRNA relative to dim-light–reared animals
over the experimental period (P $ 0.0001; one-way ANOVA;
Figs. 1A, 1B). By 12 hours of exposure, qPCR showed a 3499%
increase in Ccl2 expression relative to dim-light–reared con-
trols. Levels of Ccl2 mRNA reached a peak of 196,479% at 24
hours. In the postexposure period, Ccl2 expression fell to
5547% of control levels by 3 days and to 2092% by 7 days after
exposure. The progressive increase in Ccl2 expression ob-
served in the 24 hours of the exposure period correlated
significantly with TUNEL labeling over the same period (inter-
action 43.60% of total variance; P $ 0.0001, two-way ANOVA;
Fig. 1A). Expression of GFAP and Ccl2 also correlated signifi-
cantly in the 24-hour exposure period (interaction 42.82% of
total variance; P $ 0.0001, two-way ANOVA; Fig. 1B). How-
ever, GFAP expression in the recovery period did not show a
clear downward trend, in contrast to a progressive reduction in
expression of Ccl2 after exposure.
Localization of Ccl2 Expression
Ccl2 mRNA was not detectable by in situ hybridization in
retinas of dim-light–reared animals (Fig. 2A). However, in ex-
perimental animals at 12 hours of exposure, we detected the
expression of Ccl2 mRNA in isolated cells within the inner
nuclear layer (INL) of the superior retina (Fig. 2B); by 24 hours
BCL, we detected robust expression of Ccl2 in many cells and
FIGURE 2. In situ hybridization for
Ccl2 mRNA after exposure to BCL.
(A) Expression of Ccl2 was not de-
tectable in retinas from control, dim-
light–reared animals. (B) Ccl2 mRNA
expression was detected in isolated
cells of the INL in the superior retina
by 12 hours of BCL (arrowhead). (C)
After exposure to 24 hours of BCL,
Ccl2 mRNA was observed in cells
with radially oriented processes
throughout the INL (arrowheads).
(D) Staining was not observed with
the sense Ccl2 riboprobe in retinas
after 24 hours of BCL. (E–G) The
distribution of Ccl2 expression was
detected in a superoinferior gradient,
after BCL, with the most intense label-
ing detected in the superior retina.
(H–J) Ccl2 expression (red, arrows) in
sections counterimmunolabeled with
anti-vimentin, showing double-labeled
Müller cell processes (green; arrows,
arrowheads) indicating that Ccl2 in
the INL is expressed by Müller cells.
INL, inner nuclear layer; IPL, inner
plexiform layer; ONL, outer nuclear
layer; OPL, outer plexiform layer; RPE,
retinal pigment epithelium.
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processes in the INL (Fig. 2C), consistent with the qPCR
expression profile (Fig. 1). We also observed that Ccl2 expres-
sion was distributed in a superoinferior gradient after BCL,
with peak expression observed within the superior midperiph-
ery (Figs. 2E–G). The fluorescent markers showed that the Ccl2
mRNA (Figs. 2H–J; arrows) co-localized with the vimentin-
immunoreactive Müller cell processes (Figs. 2H–J; arrows),
suggesting that Ccl2 is initially expressed by the Müller cells.
There was no immunoreactivity (IR) for Ccl2 protein in
dim-light–reared animals (Fig. 3A), but in experimental animals
at 12 hours of exposure, some Ccl2-IR was present in radially
oriented processes in the superior retina (Figs. 3B, 3C) and in
an increasing number of processes at 24 hours of exposure
(Fig. 3D). Double immunolabeling with the Müller-cell–specific
protein S100" (Figs. 3I–K) showed Ccl2-IR localized within the
inner processes of Müller cells, consistent with the in situ
hybridization results (Fig. 2). Ccl2-IR Müller cell processes
were most prominent at 24 hours of BCL exposure (Fig. 3D)
and declined markedly in the postexposure period (Figs. 3E,
3F), so that relatively few Ccl2-IR processes were present by
7 days after exposure (Fig. 3F). As with the distribution of
Ccl2 mRNA (Fig. 2E), Ccl2-IR was predominant in Müller cell
processes in the superior retina after exposure to BCL (Figs.
3G, 3H).
Quantification of ED-1-Positive Monocytes
The histograms in Figure 4 show the number of monocytes in
the retina and choroid. The total number of monocytes in the
retina and choroid remained unchanged in the first 17 hours of
BCL exposure, but increased significantly by 24 hours of ex-
posure, compared with the dim-light–reared controls (P $
0.01, Student’s t-test; Fig. 4A). Peak numbers of monocytes
were detected at 3 days after exposure (196 cells; P $ 0.05,
Student’s t-test), which were significantly diminished by 7 days
(123 cells; P $ 0.05, Student’s t-test). The overall trend in
monocyte infiltration was found to be highly significant by
one-way ANOVA (P $ 0.0001). The counts of recruited cells in
different locations (retinal vasculature, choroid, and ONL) are
shown in Figure 4B. The data show significant monocyte re-
cruitment after BCL in both the choroid and retinal vasculature,
reaching peak numbers in the retinal vasculature by 24 hours
of exposure and in the choroid at 3 days (P $ 0.001, one-way
ANOVA). The peak number of monocytes was also detected in
the ONL by 3 days (P $ 0.01, one-way ANOVA). While a larger
number of ED-1# cells were detected in the choroid (com-
pared with the count in the retinal vessels), the data indicate
that recruitment of monocytes from the retinal vessels oc-
curred earlier than the from the choroid, with the number of
cells rising acutely from a baseline of near 0 to 16 cells per
retina, between 12 and 17 hours of BCL exposure (P $ 0.01,
Student’s t-test).
The distribution of the infiltrating monocytes along the
vertical axis of the retina is shown in Figure 5. In dim-light–
reared animals, circulating monocytes were evenly distributed
across the superior and inferior retina (Fig. 5A). By 24 hours of
BCL exposure, the monocytes were more numerous in the
superior retina by a ratio of approximately 2:1 (P $ 0.05,
Student’s t-test; Fig. 5A). By 3 days, there were more than six
times as many monocytes in the superior retina than in the
inferior retina, and the number remained elevated in the supe-
rior retina at 7 days after exposure (P $ 0.01, Student’s t-test).
A more detailed analysis of the distribution of monocytes in
adjacent fields along the vertical axis of the retina, at different
times of BCL exposure and recovery, is shown in Figure 5B.
The data indicate that monocyte numbers reached a peak at 3
days after exposure, in the region of the superior retina that
corresponds to the incipient “hot-spot” of degeneration, char-
acterized in our previous investigation.23
We also found that many infiltrating monocytes in the su-
perior retina expressed Ccl2 after exposure to BCL (Fig. 6).
After 24 hours of BCL, many infiltrating monocytes within the
choroid were Ccl2-IR (Fig. 6A–C). Extravasated tissue macro-
FIGURE 3. IR for Ccl2 in Müller cells after exposure to BCL. (A) IR for Ccl2 was not detected in control dim-light–reared retinas. (B, C) Faint Ccl2-IR
(red, arrows) was detected in thin, radial processes (arrowheads) in the INL of the superior retina at 12 hours of BCL exposure. (D) By 24 hours
of BCL exposure, Ccl2-IR was present in a large number of radial processes in the superior retina. (E, F) Lower levels of Ccl2-IR were evident during
the postexposure period. (G, H) Ccl2-IR processes were more numerous in the superior (H) compared with the inferior (G) retina. (I–M) Dual
immunolabeling for Ccl2 (red) and the Müller-cell-specific protein S100" (green) shows the co-localization of Ccl2 IR with S100" (K) in Müller cell
processes. (L) Field with inset showing co-localization of Ccl2 and S100"-IR (M) in the inner processes of Müller cells (arrows). INL, inner nuclear
layer; IPL, inner plexiform layer; ONL, outer nuclear layer.
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phages located within the outer segment layer (Fig. 6A) and the
ONL (Fig. 6D) were also strongly Ccl2-IR. Ccl2# monocytes
were observed predominately at 24 hours of BCL exposure;
none were observed in the early exposure period (12 hours
BCL), coinciding with the emergence of Ccl2 expression by
Müller cells. By the postexposure period, relatively few Ccl2-IR
monocytes were detected (data not shown).
DISCUSSION
The results of this study confirm the early and robust upregu-
lation of Ccl2 in conjunction with the light-mediated induction
of photoreceptor death and the expression of the stress-factor
GFAP, consistent with findings from previous studies.25,32 Our
data also elaborate on the role of Ccl2 in light-mediated retinal
dystrophy, through several key findings. First, both in situ
hybridization and immunohistochemistry verified that Ccl2
was expressed early by the Müller glia after exposure to BCL,
whose expression—predominately in the superior retina—was
consistent with both the temporal and spatial onset of photo-
receptor apoptosis.23,47 Second, a preferential recruitment of
monocytes to both retinal and choroidal vascular supplies
occurred in the superior retinal after the expression of Ccl2,
which correlates with the spatial distribution of Ccl2-positive
Müller cells. Third, our data show that extravasating mono-
cytes provided additional stimulatory expression of Ccl2 after
24 hours of BCL after the initial expression driven by the Müller
cells.
Although the expression of Ccl2 in light-damaged retinas
has been documented previously through PCR,32 the precise
distribution and cellular localization of Ccl2 expression after
the damaging stimulus has not, to our knowledge, been inves-
tigated. Zhang et al.25 hypothesized that Müller cells or retinal
pigment epithelial cells (RPE) may be the source of chemo-
FIGURE 4. Recruitment of mono-
cytes from the choroid and neural
retina after BCL. (A) Increased num-
ber of monocytes are detected in the
retina and choroid between 12 and
24 hours of exposure; monocytes
continued to accumulate in the ret-
ina and choroid after exposure,
reaching a peak at 3 days (P $ 0.001,
one-way ANOVA). (B) After the onset
of BCL exposure, significant mono-
cyte recruitment was observed in all
locations of the tissue examined, in-
cluding the retinal vasculature, cho-
roid, and ONL (P $ 0.05, one-way
ANOVA; n % 3 per time point; error
bars represent SEM; Asterisks denote
significant change according to Stu-
dent’s t-test, versus dim-light–reared
animals unless otherwise noted,
where *P $ 0.05 and **P $ 0.01).
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kines after BCL, and several in vitro studies have shown that
RPE cell cultures express Ccl2,48 including in response to the
introduction of stimulatory cytokines.49–53 This investigation,
however, is the first to show the preferential distribution of
Ccl2 mRNA in Müller cells in the region of the incipient lesion,
with as little as 12 hours of exposure to BCL. The findings
pinpoint a response by Müller cells—not RPE cells—as the
primary source of local Ccl2 expression, which promotes the
monocyte infiltration that is associated with light-mediated
photoreceptor apoptosis. The present findings are consistent
with those in a previous study of experimental retinal detach-
ment, which showed a rapid upregulation of Ccl2 expression
in microdissected sections of the INL and the localization of
Ccl2-IR in Müller cells that correlated with detachment-in-
duced photoreceptor death.54
Our data also demonstrate an important role for chemo-
kines in mediating local neuroinflammatory responses driven
by the neural retina. Ccl2 is a potent chemokine for monocytes
in vitro35 and is induced in a range of CNS diseases.30 Its rapid
site-specific expression by Müller cells, as demonstrated in the
present study, appears to serve as an early proinflammatory
signal that targets monocytes to sites of degeneration. We
propose that Ccl2 expression is stimulated in Müller cells as a
result of regional photoreceptor apoptosis, since increased
levels of apoptotic photoreceptors are detected around 6
hours before increased levels of Ccl2 are detected (Fig. 1A).
After Ccl2 upregulation, our data also showed preferential
infiltration of monocytes from retinal and choroidal vascular
supplies into the superior retina, consistent with our previous
findings23 and correlating with the spatial distribution of Ccl2#
Müller cells.
Perivascular monocytes express the Ccr2 chemokine recep-
tor, of which Ccl2 is a known ligand,55 and ED-1# monocytes
specifically have been shown to express Ccr2.56 Our findings
are consistent with those in previous investigations that have
established Ccl2 as a key factor in the chemotactic guidance of
monocytes after injury. An investigation in experimental retinal
detachment in Ccl2-deficient knockout mice and Ccl2-specific
antibody neutralization showed a substantial decrease in mono-
cyte recruitment after detachment in conjunction with re-
duced photoreceptor death compared with the controls.57
Similar deficiencies in monocyte recruitment have also been
reported after Ccl2 inhibition in a variety of models, including
skin inflammation,58 thioglycollate challenge,59 experimental
autoimmune encephalomyelitis,60 pulmonary granuloma,59
and peripheral endotoxin insult.61 Despite these findings, how-
ever, in a recent study, Joly et al.62 did not observe a difference
in the population of F4/80-positive macrophages in the sub-
retinal space after light-induced damage in Ccl2-knockout
mice. However, those authors did not assess the expression of
other microglial markers, such as ED-1, nor did they determine
whether the F4/80# cells expressed the Ccr2 receptor. Indeed,
a study in lung infection showed that $10% of F4/80bright cells
express Ccr2, suggesting that they are resident, rather than
recruited, macrophages.63
Our findings also show that many extravasating mono-
cytes in the superior retina display strong IR for Ccl2 after
24 hours of BCL, contributing to the vast increase in Ccl2
mRNA observed by qPCR at 24 hours of BCL. Such expres-
sion is consistent with the altered responsiveness in mono-
cytes as they differentiate to form tissue macrophages, re-
sulting in a concomitant downregulation of the Ccr2
receptor and an enhancement of Ccl2 secretion after endo-
thelial adherence.64 This modulation of Ccr2 may act as a
regulatory mechanism for controlling the extent of macro-
phage activation,64 whereas the upregulation of Ccl2 could
serve to refine and amplify the Ccl2 gradient initially laid
forth by the Müller cells.
Relevance to AMD
Our previous findings, in conjunction with those in other
studies, suggest that the light-mediated model of retinal
degeneration has several features in common with the
pathogenesis of AMD.23,65,66 This model, like the estab-
lished laser-induced model of neovascular AMD, uses an
acute damaging stimulus to evoke long-term, site-specific
retinal degeneration. We have recently shown recruitment
of monocytes/macrophages to incipient lesion on the visual
axis (area centralis) of the rat retina after BCL injury.23
Activated macrophages are associated with the progression
and severity of AMD,67 and several studies show that mac-
rophage/microglial inhibition reduce lesion size in the laser-
induced model of neovascular AMD.68 –70 The light-induced
damage model used in this study involved localized macro-
phage recruitment to the site of retinal damage23 and en-
dogenous Ccl2 expression in the neural retina (present
study). These findings provide insight into the mechanisms
that guide macrophages to regions of incipient degenera-
tion, which may be common to AMD.
Although direct studies of Ccl2 expression in the human
retina are lacking,71 it has been shown that both Ccl2- and
Ccr2-knockout mice exhibit reduced lesion size and macro-
FIGURE 5. Distribution of monocyte recruitment in relation to the
expression and IR for Ccl2 after BCL exposure. (A) The total
number of monocytes in superior and inferior regions of the retina.
There was a significant preferential recruitment of monocytes in the
superior retina after 24 hours BCL that persisted to the postexpo-
sure time points. (B) The distribution of monocytes across the
vertical meridian of the retina. At 24 hours BCL and 3 and 7 days
after exposure, monocytes were recruited primarily into the supe-
rior retina and were concentrated in a region approximately 2 mm
superior to the optic nerve (n % 4 per time point; error bars, SEM;
Asterisks denote a significant change according to Student’s t-test,
compared to the inferior retina, *P $ 0.05 and **P $ 0.01).
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phage infiltration after laser-induced choroidal neovascular-
ization compared with controls.72,73 It has been suggested
that aging Ccl2/Ccr2-knockout mice develop AMD-like reti-
nal degeneration,74 indicating that Ccl2 is also necessary for
retinal homeostasis, although the AMD-like phenotype in the
knockout has been questioned recently.72 Despite this, the
findings suggest a role for Ccl2-induced monocyte traffick-
ing in the pathogenesis of AMD, and point to a possible role
of the retina in localization of the lesions to the macula.
CONCLUSION
While the recruitment of microglia has been thought to
serve a beneficial function after retinal injury, such as pro-
moting the removal of cellular debris and apoptotic cells,5
recent evidence has suggested that the extensive microglial
activation induced in BCL is detrimental.26 Our data demon-
strate that monocyte recruitment after light-mediated cell
death correlates with both the temporal and spatial expres-
sion of Ccl2 by Müller cells, which supports a role of the
neural retina in guiding neuroinflammatory responses of
microglia after damage. The potential modulation of such
endogenous chemokine responses may provide a powerful
means of controlling excessive microglial recruitment and
activation, which has relevance in the treatment of human
diseases such as AMD.
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